◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › I › ICUI

ICU Medical Inc (ICUI) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · DATA UPDATED 2026-08-22

ICU Medical Inc (ICUI) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in San Clemente, United States with about 13,000 employees. Its market capitalization is roughly $4 billion. In the fiscal year ended 2025-12-31, ICUI reported $2.2B in revenue and $1M in net income.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide.

Interactive charts & full statements → Open the ICUI valuation workbench →

ICUI Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$2.2B	$2.2B	$2.4B	$2.3B	$2.3B	$1.3B	$1.3B	$1.3B	$1.4B	$1.3B	$379M	$342M	$309M	$314M	$317M	$302M	$285M	$232M	$205M	$188M	$202M
Gross Profit	$811M	$820M	$825M	$740M	$698M	$491M	$461M	$472M	$570M	$426M	$201M	$181M	$151M	$155M	$157M	$142M	$131M	$109M	$90M	$78M	$81M
Gross Margin %	37.6%	36.8%	34.6%	32.8%	30.6%	37.3%	36.3%	37.3%	40.7%	33.0%	53.1%	52.9%	49.0%	49.3%	49.4%	47.1%	45.9%	47.0%	43.9%	41.6%	40.0%
Operating Income (EBIT)	$109M	$107M	$43M	$23M	($43M)	$123M	$98M	$107M	$22M	($15M)	$83M	$69M	$39M	$52M	$61M	$65M	$49M	$38M	$31M	$25M	$31M
Operating Margin %	5.0%	4.8%	1.8%	1.0%	-1.9%	9.4%	7.7%	8.5%	1.5%	-1.2%	21.9%	20.1%	12.6%	16.6%	19.3%	21.6%	17.3%	16.4%	15.3%	13.1%	15.3%
Net Income	$30M	$1M	($118M)	($30M)	($74M)	$103M	$87M	$101M	$29M	$69M	$63M	$45M	$26M	$40M	$41M	$45M	$31M	$27M	$24M	$23M	$26M
Net Margin %	1.4%	0.0%	-4.9%	-1.3%	-3.3%	7.8%	6.8%	8.0%	2.1%	5.3%	16.6%	13.2%	8.5%	12.9%	13.0%	14.8%	10.9%	11.5%	11.9%	12.3%	12.7%
EBITDA	$298M	$327M	$43M	$253M	$192M	$223M	$194M	$192M	$272M	$206M	$118M	$100M	$64M	$73M	$80M	$85M	$65M	$52M	$41M	$28M	$36M
Earnings Per Share (EPS)	$1.18	$0.03	$-4.83	$-1.23	$-3.11	$4.74	$4.02	$4.69	$1.33	$3.29	$3.66	$2.73	$1.68	$2.65	$2.80	$3.15	$2.23	$1.77	$1.67	$1.51	$1.64
Shares Outstanding (M)	25M	25M	24M	24M	24M	22M	22M	22M	22M	21M	17M	16M	16M	15M	15M	14M	14M	15M	15M	15M	16M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ICUI Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$552M	$530M	$540M	$537M	$549M	$605M	$630M	$589M
Gross Profit	$235M	$173M	$202M	$201M	$208M	$210M	$227M	$205M
Gross Margin %	42.6%	32.6%	37.4%	37.4%	37.9%	34.8%	36.1%	34.8%
Operating Income (EBIT)	$39M	$31M	$25M	$14M	$11M	$13M	$38M	$8M
Operating Margin %	7.1%	5.8%	4.7%	2.5%	1.9%	2.1%	6.0%	1.4%
Net Income	$19M	$30M	($16M)	($3M)	$35M	($15M)	($24M)	($33M)
Net Margin %	3.5%	5.7%	-2.9%	-0.6%	6.4%	-2.6%	-3.8%	-5.6%
EBITDA	$141M	$29M	$61M	$67M	$106M	$64M	$87M	$65M
Earnings Per Share (EPS)	$0.76	$1.20	$-0.64	$-0.14	$1.43	$-0.63	$-0.97	$-1.35
Shares Outstanding (M)	25M	25M	25M	25M	25M	25M	24M	24M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ICUI Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$236M	$180M	$204M	$166M	($62M)	$268M	$223M	$102M	$160M	$154M	$90M	$55M	$61M	$64M	$66M	$64M	$33M	$49M	$30M	$42M	$32M
Capital Expenditures (CapEx)	$84M	$88M	$79M	$94M	$99M	$81M	$100M	$106M	$101M	$80M	$25M	$14M	$18M	$19M	$20M	$16M	$23M	$17M	$11M	$24M	$20M
Free Cash Flow (FCF)	$153M	$92M	$125M	$73M	($161M)	$186M	$122M	($4M)	$59M	$75M	$65M	$41M	$43M	$45M	$46M	$49M	$10M	$32M	$19M	$18M	$12M
FCF Margin %	7.1%	4.1%	5.2%	3.2%	-7.1%	14.2%	9.6%	-0.3%	4.2%	5.8%	17.2%	12.0%	13.9%	14.2%	14.5%	16.1%	3.5%	13.8%	9.2%	9.5%	5.9%
Dividends Paid	—	—	—	$9M	$11M	$1M	$0M	—	—	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ICUI Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$80M	$39M	$61M	$57M	$11M	$51M	$40M	$36M
Capital Expenditures (CapEx)	$19M	$11M	$25M	$29M	$22M	$15M	$27M	$15M
Free Cash Flow (FCF)	$62M	$28M	$36M	$28M	($11M)	$37M	$14M	$22M
FCF Margin %	11.2%	5.2%	6.7%	5.1%	-2.0%	6.1%	2.2%	3.7%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ICUI Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$4.0B	$4.1B	$4.2B	$4.4B	$4.5B	$1.9B	$1.8B	$1.7B	$1.6B	$1.5B	$705M	$627M	$541M	$500M	$429M	$364M	$312M	$309M	$283M	$243M	$244M
Cash & Cash Equivalents	$298M	$308M	$309M	$254M	$209M	$553M	$396M	$269M	$345M	$290M	$445M	$336M	$276M	$226M	$147M	$100M	$79M	$51M	$56M	$8M	$13M
Total Liabilities	$1.8B	$1.9B	$2.2B	$2.3B	$2.4B	$265M	$261M	$315M	$322M	$299M	$45M	$47M	$33M	$35M	$38M	$41M	$38M	$44M	$30M	$29M	$19M
Total Debt (Short + Long-Term)	$1.2B	$1.3B	$1.6B	$1.6B	$1.7B	$9M	$9M	$7M	$6M	$9M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M
Total Shareholders' Equity	$2.2B	$2.1B	$2.0B	$2.1B	$2.1B	$1.6B	$1.5B	$1.4B	$1.3B	$1.2B	$660M	$580M	$508M	$465M	$391M	$323M	$274M	$265M	$253M	$214M	$225M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ICUI viewer.

Other Companies in MEDICAL INSTRUMENTS & SUPPLIES

BLCO · Bausch + Lomb Corp — $6 billion
STVN · Stevanato Group SpA — $6 billion
MMSI · Merit Medical Systems Inc — $5 billion
PLSE · Pulse Biosciences Inc — $4 billion
NVST · Envista Holdings Corp — $4 billion
ATRC · AtriCure Inc — $3 billion
XRAY · Dentsply Sirona Inc — $2 billion
LMAT · LeMaitre Vascular Inc — $2 billion

← ICU All “I” companies ICVT →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.